Certain Warrants of Dermata Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 16-MAY-2023. These Warrants will be under lockup for 61 days starting from 16-MAR-2023 to 16-MAY-2023.

Details:
The company and each of the officers and directors have agreed with the placement agent to be subject to a lock-up period of sixty (60) days following the date of this prospectus. During the applicable lock-up period, company may not offer for sale, contract to sell, or sell any shares of common stock or any securities convertible into, or exercisable or exchangeable for, shares of common stock subject to certain customary exception such as issuing stock options to directors, officers, employees and consultants under existing plans.